ask="7.20"
ask_size="700"
average_daily_volume="42611"
bid="4.02"
bid_size="100"
book_value="5.08"
change="-0.05"
change_from_200_day_moving_average="-0.69"
change_from_50_day_moving_average="-0.41"
change_from_52_week_high="-7.81"
change_From_52_week_low="1.05"
change_in_percent="-1.00%"
close="4.94"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.45"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.20"
high_52_weeks="12.75"
last_trade_date="1/5/2017"
last_trade_price="4.94"
last_trade_size="100"
last_trade_time="4:00pm"
low="4.71"
low_52_weeks="3.89"
market_capitalization="66.34M"
moving_average_200_day="5.63"
moving_average_50_day="5.35"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="16.33"
open="5.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.33%"
percent_change_from_50_day_moving_average="-7.66%"
percent_change_from_52_week_high="-61.25%"
percent_change_from_52_week_low="+26.99%"
previous_close="4.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.98"
price_per_sales="13.49"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.21"
stock_exchange="NGM"
symbol="AGLE"
volume="13235"
weeks_range_52="3.89 - 12.75"
